Showing results (331-340 of 1,398) with videos related to

Sort By:
Pageof 140
Drug Development Research|December 5, 2019
New 3-unsubstituted isoxazolones as potent human neutrophil elastase inhibitors: Synthesis and molecular dynamic simulationMaria Paola Giovannoni, Letizia Crocetti, Niccolò Cantini, et al.
Drug Development Research|July 8, 2022
Engineering of A3 Adenosine and P2Y Nucleotide Receptors and Their LigandsKenneth A Jacobson, Hak Sung Kim, Gnana Ravi, et al.
Drug Development Research|June 18, 2022
A new exploration toward adamantane derivatives as potential anti-MDR agents: Design, synthesis, antimicrobial, and radiosterilization activity as potential topoisomerase IV and DNA gyrase inhibitorsAhmed Ragab, Moustafa S Abusaif, Dina S Aboul-Magd, et al.
Drug Development Research|January 9, 2023
PDE4 inhibitor Roflumilast modulates inflammation and lipid accumulation in PCOS mice to improve ovarian function and reduce DHEA-induced granulosa cell apoptosis in vitroXiaowei Ji, Yao Ye, Lin Wang, et al.
Drug Development Research|December 21, 2022
Therapeutic role of Artemether in the prevention of hepatic steatosis through miR-34a-5p/PPARα pathwayLi Chen, Shuang Yu, Shubing Hong, et al.
Drug Development Research|December 3, 2022
Multitargeted C9-substituted ester and ether derivatives of berberrubine for Alzheimer's disease: Design, synthesis, biological evaluation, metabolic stability, and pharmacokineticsRinky Raghuvanshi, Ashiya Jamwal, Utpal Nandi, et al.
Drug Development Research|December 5, 2022
Anlotinib improves bile duct ligature-induced liver fibrosis in rats via antiangiogenesis regulated by VEGFR2/mTOR pathwayJun Lei, Qing Li, Hongyan Xu, et al.
Drug Development Research|June 24, 2022
Quercetin ameliorates salivary gland apoptosis and inflammation in primary Sjögren's syndrome through regulation of the leptin/OB-R signalingLihua Chang, Aibin Kong, Yun Guo, et al.
Drug Development Research|June 25, 2022
The potential of developing a protective peptide-based vaccines against SARS-CoV-2Ahmed O Shalash, Istvan Toth, Mariusz Skwarczynski
Drug Development Research|May 22, 2019
Efficacy of a phenol derivative, isopropyl vanillate, as an anti-inflammatory agent: A new small molecule inhibitor of COX and neutrophil migrationKerolayne M Nogueira, Luan K M de Souza, Ana P de Oliveira, et al.
Pageof 140